Gut dysbiosis exacerbates inflammatory liver injury induced by environmentally relevant concentrations of nanoplastics via the gut-liver axis

被引:0
|
作者
Xia, Sugan [1 ,2 ,3 ]
Yan, Chaoyue [1 ,2 ]
Cai, Guodong [1 ,2 ]
Xu, Qingyu [1 ,2 ]
Zou, Hui [1 ,2 ,3 ]
Gu, Jianhong [1 ,2 ]
Yuan, Yan [1 ,2 ]
Liu, Zongping [1 ,2 ,3 ]
Bian, Jianchun [1 ,2 ,3 ]
机构
[1] Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Peoples R China
[2] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Peoples R China
[3] Yangzhou Univ, Joint Int Res Lab Agr & Agriprod Safety, Minist Educ China, Yangzhou 225009, Peoples R China
来源
基金
国家重点研发计划;
关键词
Nanoplastics; Pyroptosis; Gut microbiota; Inflammatory liver injury; Intestinal barrier; MICROBIOTA;
D O I
10.1016/j.jes.2024.11.022
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
As an emerging and potentially threatening pollutant, nanoplastics (NPs) have received considerable global attention. Due to their physical properties and diminutive size, NPs ingestion can more easily cross biological barriers and enter the human and animal body. Despite reports of hepatotoxicity associated with NPs, their impact and potential underlying mechanisms remain elusive. In this study, we investigated the impact of NPs at concentrations found in the environment on the gut flora, intestinal barrier function, liver pyroptosis, and inflammation in mice following 12 weeks of exposure. To further validate the involvement of gut flora in inflammatory liver damage caused by NPs, we utilized antibiotics to remove the intestinal flora and performed fecal microbiota transplantation. We confirmed that NPs exposure altered the gut microbiota composition, with a notable rise in the proportions of Alloprevotella and Ileibacterium while causing a decrease in the relative proportions of Dubosiella. This disruption also affected the gut barrier, increasing lipopolysaccharides in circulation and promoting liver pyroptosis. Importantly, mice receiving fecal transplants from NPs-treated mice showed intestinal barrier damage, liver pyroptosis, and inflammation. However, NPs effects on the intestinal barrier and liver pyroptosis were attenuated by antibiotics depletion of the commensal microbiota. In summary, our current research revealed that extended exposure to environmentally relevant concentrations of NPs resulted in inflammatory damage to the liver. Additionally, we have identified for the first time that imbalances in intestinal flora are crucial in liver pyroptosis induced by NPs. (c) 2025 The Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences. Published by Elsevier B.V.
引用
收藏
页码:250 / 266
页数:17
相关论文
共 50 条
  • [31] The gut-liver axis in HCV infection
    Newman, Kira L. L.
    Kamada, Nobuhiko
    NATURE MICROBIOLOGY, 2023, 8 (01) : 6 - 7
  • [32] Diammonium glycyrrhizinate alleviates iron overload-induced liver injury in mice via regulating the gut-liver axis
    Liu, Yu
    Li, Xiaohong
    Guo, Ziwei
    Li, Guangyan
    He, Lu
    Liu, Huan
    Cai, Shuang
    Huo, Taoguang
    PHYTOMEDICINE, 2024, 135
  • [33] Exploring the Relationship between Liver Disease, Bacterial Translocation, and Dysbiosis: Unveiling the Gut-Liver Axis
    Juanola, Oriol
    Frances, Ruben
    Caparros, Esther
    VISCERAL MEDICINE, 2024, 40 (01) : 12 - 19
  • [34] The gut-liver axis and the intersection with the microbiome
    Tripathi, Anupriya
    Debelius, Justine
    Brenner, David A.
    Karin, Michael
    Loomba, Rohit
    Schnabl, Bernd
    Knight, Rob
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (07) : 397 - 411
  • [35] DHA-enriched phosphatidylserine ameliorates cyclophosphamide-induced liver injury via regulating the gut-liver axis
    Zhang, Honglei
    Lu, Yun
    Zhang, Yuanlei
    Dong, Jiayu
    Jiang, Su
    Tang, Yunping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 140
  • [36] Gut-Liver Axis and Sensing Microbes
    Szabo, Gyongyi
    Bala, Shashi
    Petrasek, Jan
    Gattu, Arijeet
    DIGESTIVE DISEASES, 2010, 28 (06) : 737 - 744
  • [37] The gut-liver axis in hepatobiliary diseases
    Masataka Ichikawa
    Haruka Okada
    Nobuhiro Nakamoto
    Nobuhito Taniki
    Po-Sung Chu
    Takanori Kanai
    Inflammation and Regeneration, 44
  • [38] The gut-liver axis in hepatobiliary diseases
    Ichikawa, Masataka
    Okada, Haruka
    Nakamoto, Nobuhiro
    Taniki, Nobuhito
    Chu, Po-Sung
    Kanai, Takanori
    INFLAMMATION AND REGENERATION, 2024, 44 (01)
  • [39] The gut-liver axis as a target of liver disease management
    Mandato, Claudia
    Bovi, Anna Pia Delli
    Vajro, Pietro
    HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (01) : 100 - 102
  • [40] Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
    Fukui, Hiroshi
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (03) : 425 - 442